4価ワクチンの世界市場レポート 2024年

4価ワクチン市場規模は近年力強く成長しています。2023年の82億8,000万米ドルから2024年には89億8,000万米ドルに、CAGR8.4％で成長します。過去の期間に観察された成長は、疾患の複雑さ、教育イニシアティブ、過去の健康イベント、ヘルスケアにおける全体的な拡大、技術の進歩などの要因に起因しています。

4価ワクチン市場の成長が期待される背景には、世界の予防接種率の拡大もあります。定義された期間内に特定のワクチンを接種した人口の割合を示す予防接種率は、ワクチン需要の増加を促進します。4種類の株を予防する4価ワクチンワクチンは、1回の接種で複数の病気の脅威に対処するため、定期的なワクチン接種プログラムに組み込まれることが多いです。世界保健機関（WHO）は、接種ゼロの子どもの数が改善し、2021年の1,810万人から2022年には1,430万人に減少すると報告しています。さらに、女児におけるヒトパピローマウイルス（HPV）ワクチンの世界の初回接種率は、2021年の16％から2022年には21％に上昇しました。このように、世界の予防接種率の上昇は、4価ワクチン市場を前進させると予想されます。

2023年の4価ワクチン市場で最大の地域は北米でした。4価ワクチン市場レポートがカバーしている地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 4価ワクチン市場の特徴

第3章 4価の市場動向と戦略

第4章 4価ワクチン市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の4価ワクチン市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 4価ワクチン市場セグメンテーション

• 世界の4価ワクチン市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 皮内注射
• 筋肉注射
• 点鼻薬
• 世界の4価ワクチン市場、技術別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• コンジュゲート
• 生
• 不活化
• 組換え
• トキソイド
• その他の技術
• 世界の4価ワクチン市場、疾患別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• がん
• 肝炎
• 肺炎球菌疾患
• COVID-19
• インフルエンザ
• ヒトパピローマウイルス
• 髄膜炎菌性疾患
• ポリオ
• ロタウイルス
• その他の病気
• 世界の4価ワクチン市場、年齢層別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 小児
• 大人
• 世界の4価ワクチン市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院と薬局
• 政府のサプライヤー
• その他のチャネル（NGO）

第7章 4価ワクチン市場の地域および国分析

• 世界の4価ワクチン市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の4価ワクチン市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の4価ワクチン市場

第9章 中国の4価ワクチン市場

第10章 インドの4価ワクチン市場

第11章 日本の4価ワクチン市場

第12章 オーストラリアの4価ワクチン市場

第13章 インドネシアの4価ワクチン市場

第14章 韓国の4価ワクチン市場

第15章 西欧の4価ワクチン市場

第16章 英国の4価ワクチン市場

第17章 ドイツの4価ワクチン市場

第18章 フランスの4価ワクチン市場

第19章 イタリアの4価ワクチン市場

第20章 スペインの4価ワクチン市場

第21章 東欧の4価ワクチン市場

第22章 ロシアの4価ワクチン市場

第23章 北米の4価ワクチン市場

第24章 米国の4価ワクチン市場

第25章 カナダの4価ワクチン市場

第26章 南米の4価ワクチン市場

第27章 ブラジルの4価ワクチン市場

第28章 中東の4価ワクチン市場

第29章 アフリカの4価ワクチン市場

第30章 4価ワクチン市場の競合情勢と企業プロファイル

• 4価ワクチン市場の競合情勢
• 4価ワクチン市場の企業プロファイル
  • AstraZeneca Plc
  • Serum Institute of India Private Limited
  • Sanofi SA
  • GlaxoSmithKline Plc
  • CSL Limited

第31章 世界の4価ワクチン市場の競合ベンチマーキング

第32章 世界の4価ワクチン市場競争力ダッシュボード

第33章 4価ワクチン市場における主要な合併と買収

第34章 4価ワクチン市場の将来展望と可能性分析

第35章 付録

“Quadrivalent Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quadrivalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quadrivalent? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The quadrivalent market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Intradermal Shot; Intramuscular Injection; Nasal Spray
• 2) By Technology: Conjugated; Live; Inactivated; Recombinant; Toxoid; Other Technologies
• 3) By Disease: Cancer; Hepatitis; Pneumococcal disease; COVID-19; Influenza; Human Papilloma Virus; Meningococcal Disease; Polio; Rotavirus; Other Diseases
• 4) By Age Group: Pediatric; Adult
• 5) By Distribution Channel: Hospital And Pharmacy; Government Suppliers; Other Channels (NGOs)
• Companies Mentioned: AstraZeneca Plc; Serum Institute of India Private Limited; Sanofi S.A.; GlaxoSmithKline Plc; CSL Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A quadrivalent vaccine stimulates the immune system to respond to distinct antigens, typically targeting four different viruses or bacteria. In the context of influenza, a quadrivalent vaccine is designed to provide protection against four specific flu viruses, including two type A and two type B viruses.

The primary types of quadrivalent vaccines include intradermal shots, intramuscular injections, and nasal sprays. An intradermal shot involves injecting the vaccine between the epidermis and hypodermis, the top and bottom layers of the skin, as defined by the Center for Disease Control (CDC). These vaccines are formulated using various technologies, including conjugated, live, inactivated, recombinant, toxoid, and others, aiming to immunize against a range of diseases such as cancer, hepatitis, pneumococcal disease, COVID-19, influenza, human papillomavirus, meningococcal disease, polio, rotavirus, and others affecting both pediatric and adult age groups. Distribution channels for these vaccines include hospitals, pharmacies, government suppliers, and other outlets.

The quadrivalent market research report is one of a series of new reports from The Business Research Company that provides quadrivalent market statistics, including quadrivalent industry global market size, regional shares, competitors with a quadrivalent market share, detailed quadrivalent market segments, market trends and opportunities, and any further data you may need to thrive in the quadrivalent industry. This quadrivalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quadrivalent market size has grown strongly in recent years. It will grow from $8.28 billion in 2023 to $8.98 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to factors such as the complexity of diseases, educational initiatives, past health events, overall expansion in healthcare, and technological progress.

The quadrivalent market size is expected to see strong growth in the next few years. It will grow to $12.88 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The anticipated growth in the forecast period can be attributed to factors such as global health events, competitive dynamics, educational campaigns, regulatory changes, and the evolving patterns of diseases. Key trends expected in the forecast period include disease prevalence, the regulatory environment, healthcare infrastructure, consumer awareness and education, and the competitive landscape.

The anticipated rise in the prevalence of chronic and infectious diseases is set to drive the growth of the quadrivalent market. Chronic diseases, attributed to genetics and lifestyle, and infectious diseases caused by agents such as viruses, bacteria, fungi, or protozoa, pose significant health challenges. Quadrivalent vaccines play a crucial role in preventing morbidity and mortality from serious infections, addressing diseases beyond their targeted infections. These vaccines are increasingly employed in preventing chronic diseases associated with infectious agents involved in carcinogenesis. According to the World Health Organization (WHO), 17 million people succumb to chronic or noncommunicable diseases (NCDs) annually, and in 2021, there were an estimated 247 million cases of malaria globally, resulting in approximately 619,000 fatalities. Thus, the escalating prevalence of chronic and infectious diseases is a driving force behind the quadrivalent market's growth.

The expected growth in the quadrivalent market is also fueled by the global expansion of immunization coverage. Immunization coverage, indicating the proportion of a population receiving specific vaccines within a defined period, drives increased demand for vaccines. Quadrivalent vaccines, protecting against four strains, are often integrated into routine vaccination programs to combat multiple disease threats in a single shot. The World Health Organization reported an improvement in the number of zero-dose children, decreasing from 18.1 million in 2021 to 14.3 million in 2022. Moreover, global coverage for the initial dose of the human papillomavirus (HPV) vaccine in girls increased from 16% in 2021 to 21% in 2022. Thus, the rising global immunization coverage is expected to propel the quadrivalent market forward.

A key trend gaining prominence in the quadrivalent market is product innovation. Major companies in the sector are actively developing innovative solutions to reinforce their market positions. AstraZeneca, a UK-based pharmaceutical company, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal) in September 2022. This FDA-approved nasal-spray flu vaccine for individuals aged 2 to 49 is administered through a needle-free nasal spray. It is available in trivalent or quadrivalent formulations, providing a live attenuated influenza vaccine (LAIV) covered by most health insurance plans and the vaccines for children program.

Major companies in the quadrivalent market are strategically introducing innovative products such as Narcan to drive market revenues. Narcan (naloxone hydrochloride) nasal spray 4 mg is designed to reverse opioid overdoses during a surge in overdose deaths. Sandoz International GmbH, a Germany-based pharmaceutical company, launched Narcan in December 2021. This nasal spray quickly blocks the effects of opioids on the brain, restoring normal breathing and consciousness in individuals experiencing an overdose. It is specifically designed to rapidly reverse the life-threatening effects of an opioid overdose.

In February 2023, China-based biotechnology company Clover Biopharmaceuticals Ltd. entered into a partnership with Adimmune Corporation, a Taiwan-based biopharmaceutical company. This collaboration leverages Adimmune's manufacturing and distribution expertise in providing essential vaccines to Asian populations. Clover aims to strengthen its position as a premier respiratory vaccine franchise and enhance synergies with ongoing COVID-19 vaccine commercialization. As part of this collaboration, Clover will distribute Adimmune's AdimFlu-S (QIS), the only imported quadrivalent influenza vaccination authorized in mainland China, utilizing its established commercial infrastructure.

Major companies operating in the quadrivalent market report are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., Xenetic Biosciences Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Hoffmann-La Roche Ltd., Gamma Vaccines Pty Ltd., Biodiem Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., MedImmune, Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG) .

North America was the largest region in the quadrivalent market in 2023. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quadrivalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quadrivalent market consists of sales of afluria quadrivalent, fluarix quadrivalent, flublok quadrivalent, fluzone quadrivalent (influenza virus vaccine), flulaval quadrivalent, flucelvax quadrivalent, menactra and menveo. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Quadrivalent Market Characteristics

3. Quadrivalent Market Trends And Strategies

4. Quadrivalent Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Quadrivalent Market Size and Growth

• 5.1. Global Quadrivalent Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Quadrivalent Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Quadrivalent Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Quadrivalent Market Segmentation

• 6.1. Global Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Intradermal Shot
• Intramuscular Injection
• Nasal Spray
• 6.2. Global Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Conjugated
• Live
• Inactivated
• Recombinant
• Toxoid
• Other Technologies
• 6.3. Global Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cancer
• Hepatitis
• Pneumococcal disease
• COVID-19
• Influenza
• Human Papilloma Virus
• Meningococcal Disease
• Polio
• Rotavirus
• Other Diseases
• 6.4. Global Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pediatric
• Adult
• 6.5. Global Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital And Pharmacy
• Government Suppliers
• Other Channels (NGOs)

7. Quadrivalent Market Regional And Country Analysis

• 7.1. Global Quadrivalent Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Quadrivalent Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Quadrivalent Market

• 8.1. Asia-Pacific Quadrivalent Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Quadrivalent Market

• 9.1. China Quadrivalent Market Overview
• 9.2. China Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Quadrivalent Market

• 10.1. India Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Quadrivalent Market

• 11.1. Japan Quadrivalent Market Overview
• 11.2. Japan Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Quadrivalent Market

• 12.1. Australia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Quadrivalent Market

• 13.1. Indonesia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Quadrivalent Market

• 14.1. South Korea Quadrivalent Market Overview
• 14.2. South Korea Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Quadrivalent Market

• 15.1. Western Europe Quadrivalent Market Overview
• 15.2. Western Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Quadrivalent Market

• 16.1. UK Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Quadrivalent Market

• 17.1. Germany Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Quadrivalent Market

• 18.1. France Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Quadrivalent Market

• 19.1. Italy Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Quadrivalent Market

• 20.1. Spain Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Quadrivalent Market

• 21.1. Eastern Europe Quadrivalent Market Overview
• 21.2. Eastern Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Quadrivalent Market

• 22.1. Russia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Quadrivalent Market

• 23.1. North America Quadrivalent Market Overview
• 23.2. North America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Quadrivalent Market

• 24.1. USA Quadrivalent Market Overview
• 24.2. USA Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Quadrivalent Market

• 25.1. Canada Quadrivalent Market Overview
• 25.2. Canada Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Quadrivalent Market

• 26.1. South America Quadrivalent Market Overview
• 26.2. South America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Quadrivalent Market

• 27.1. Brazil Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Quadrivalent Market

• 28.1. Middle East Quadrivalent Market Overview
• 28.2. Middle East Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Quadrivalent Market

• 29.1. Africa Quadrivalent Market Overview
• 29.2. Africa Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Quadrivalent Market Competitive Landscape And Company Profiles

• 30.1. Quadrivalent Market Competitive Landscape
• 30.2. Quadrivalent Market Company Profiles
  • 30.2.1. AstraZeneca Plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Serum Institute of India Private Limited
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Sanofi S.A.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GlaxoSmithKline Plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. CSL Limited
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Quadrivalent Market Competitive Benchmarking

32. Global Quadrivalent Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Quadrivalent Market

34. Quadrivalent Market Future Outlook and Potential Analysis

• 34.1 Quadrivalent Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Quadrivalent Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Quadrivalent Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer